Neutralizing Antibodies Response to Novel SARS-CoV-2 Omicron Sublineages in Long-term Care Facility Residents After the Fourth Dose of Monovalent BNT162b2 COVID-19 Vaccination
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Evaluating the Quality of Studies Assessing COVID-19 Vaccine Neutralizing Antibody Immunogenicity.
Katzmarzyk M, Naughton R, Sitaras I, Jacobsen H, Higdon M, Knoll M Vaccines (Basel). 2024; 12(11).
PMID: 39591141 PMC: 11598362. DOI: 10.3390/vaccines12111238.
Karismananda , Hasyim A, Sakamoto A, Yamagata K, Zainal K, Suparman D Antibodies (Basel). 2024; 13(3).
PMID: 39311377 PMC: 11417924. DOI: 10.3390/antib13030072.